A day of contrasts: Navigating emotions in oncology

MORNING: A TRAGIC GOODBYE

The day began with a scheduled meeting with the parents of Mr. A, a young man of 19 years who had recently succumbed to metastatic malignant melanoma. Mr. A had initially responded well to chemotherapy and immunotherapy, bringing a glimmer of hope to an otherwise bleak diagnosis. Unfortunately, his cancer later progressed, necessitating a second-line treatment. Despite the medical team’s best efforts, Mr. A’s condition worsened due to complications associated with his escalating disease burden, and he ultimately passed away.

Mr. A’s parents sat before me, their grief palpable and profound. As I listened to their anguish, their disbelief over the abrupt shift in Mr. A’s condition was evident. “We just don’t understand how this happened,” Mr. A’s mother said, her voice breaking. Despite extensive counselling from both the oncological and palliative care teams throughout Mr. A’s treatment course, including detailed documentation in our electronic medical records, they struggled to comprehend how such hope had turned so tragically.

This encounter illuminated the necessity of continual and empathetic communication throughout a patient’s journey, reinforcing the importance of well-documented records to support transparency and clarity in medical care. These steps are vital, not only as part of comprehensive patient care but also as measures to prevent potential medicolegal issues. Ensuring that families are repeatedly and sensitively informed about the realities of treatment expectations and potential outcomes is essential in the face of such devastating losses.

AFTERNOON: THE COMPLEXITY OF CHOICES

Later that day, I met with the family of Mr. B, a 69-year-old patient with metastatic prostate cancer. Mr. B had exhausted three lines of therapy and was eager to pursue further treatment with Lu¹⁷⁷ prostate-specific membrane antigen (PSMA) therapy, as suggested by a collaborative assessment from the Medical Oncology and Nuclear Medicine teams. His scans indicated promising PSMA avidity, suggesting the potential effectiveness of the therapy.

However, his family was apprehensive about the possible toxicities associated with this new treatment. In a lengthy discussion, we addressed their concerns, detailing potential side effects and the rationale for pursuing this option despite previous treatment failures. Ultimately, after careful deliberation, Mr. B and his family consented in writing to proceed with the PSMA therapy.

Tragically, 2 weeks following his first dose, Mr. B developed a severe urinary tract infection and sepsis, which led to his demise despite our team’s exhaustive efforts. In their grief, his family expressed regret and anger, believing that the treatment’s toxicities had hastened his demise. “Would he have been better off without further treatment?” They questioned, haunted by various “what-ifs”.

This scenario underscored that the delicate balance oncologists must maintain between offering hope through treatment and conveying the potential risks involved, especially in complex cases like Mr. B’s. The family’s reaction highlighted their short-lived hope turning into regret, a transformation that often occurs in the shadow of aggressive treatment courses.

REFLECTIONS

These contrasting experiences shed light on the dual nature of oncology practice – navigating both the promise of life-extending treatments and the realities of their limits. Such events are reminders that the science of medicine cannot be separated from the art of compassionate, clear, and continuous dialog. Mr. A’s journey reiterates the profound impact of comprehensive documentation and the essential role it plays in both patient care and the broader legal landscape. Meanwhile, Mr. B’s experience highlighted the persistent need for vigilance in managing family expectations and regrets, a task as challenging as the treatments themselves.

The blend of hope and despair accompanying every decision in oncology is a testament to the human elements ingrained deeply in this field. Each patient and family interaction is an opportunity to reinforce trust, understanding, and mutual decision-making, ensuring that the complexities of treatment are matched by the depth of compassion offered. Ultimately, the corridors of oncology are lined with stories of resilience, heartache, and humanity, each reminding us of the intricacies of life and the noble pursuit of healing.